Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Roundtable on Value and Science-Driven Health Care"'
Autor:
Institute of Medicine, Roundtable on Value and Science-Driven Health Care, Julia Sanders, Brian Powers, Claudia Grossmann
Digital health data are the lifeblood of a continuous learning health system. A steady flow of reliable data is necessary to coordinate and monitor patient care, analyze and improve systems of care, conduct research to develop new products and approa
Autor:
Institute of Medicine, Roundtable on Value and Science-Driven Health Care, J. Michael McGinnis, Brian Powers, Claudia Grossmann
Like many other industries, health care is increasingly turning to digital information and the use of electronic resources. The Institute of Medicine's Roundtable on Value & Science-Driven Health Care hosted three workshops to explore current efforts
Autor:
Institute of Medicine, Roundtable on Value and Science-Driven Health Care, J. Michael McGinnis, LeighAnne Olsen
Recent scientific and technological advances have accelerated our understanding of the causes of disease development and progression, and resulted in innovative treatments and therapies. Ongoing work to elucidate the effects of individual genetic var
Autor:
Institute of Medicine, Roundtable on Value and Science-Driven Health Care, J. Michael McGinnis, LeighAnne Olsen, W. Alexander Goolsby, Claudia Grossmann
Successful development of clinical data as an engine for knowledge generation has the potential to transform health and health care in America. As part of its Learning Health System Series, the Roundtable on Value & Science-Driven Health Care hosted
Autor:
Institute of Medicine, Roundtable on Value and Science-Driven Health Care, Claudia Grossmann, Joe Alper
Health care has been called one of the most complex sectors of the U.S. economy. Driven largely by robust innovation in treatments and interventions, this complexity has created an increased need for evidence about what works best for whom in order t
The Institute of Medicine\'s Roundtable on Value & Science-Driven Health Care held a workshop, titled Partnering with Patients to Drive Shared Decisions, Better Value, and Care Improvement, on February 25 and 26, 2013. The workshop, supported by the
Autor:
Institute of Medicine, Board on Health Sciences Policy, Forum on Drug Discovery, Development, and Translation, Roundtable on Value and Science-Driven Health Care, Rebecca A. English, Julia Sanders, Claudia Grossmann
Randomized clinical trials (RCTs) are often referred to as the'gold standard'of clinical research. However, in its current state, the U.S. clinical trials enterprise faces substantial challenges to the efficient and effective conduct of research. Str
Autor:
Institute of Medicine, Roundtable on Value and Science-Driven Health Care, Robert Saunders, Julia Sanders, Joe Alper
Health care quality and its affordability have become very pressing issues in the United States. All sectors of the country are attempting to push forward initiatives that will improve the health care system as well as the health of the American popu
Autor:
Institute of Medicine, Roundtable on Value and Science-Driven Health Care, A Learning Health System Activity, Joe Alper, Claudia Grossmann
Clinical research strains to keep up with the rapid and iterative evolution of medical interventions, clinical practice innovation, and the increasing demand for information on the clinical effectiveness of these advancements. In response to the grow
Autor:
Institute of Medicine, Roundtable on Value and Science-Driven Health Care, J. Michael McGinnis, Robert S. Saunders, LeighAnne Olsen
As past, current, or future patients, the public should be the health care system's unwavering focus and serve as change agents in its care. Taking this into account, the quality of health care should be judged not only by whether clinical decisions